Cargando…
Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy
Methotrexate (MTX)‐induced encephalopathy is a grave complication in patients with malignancies. The early diagnosis of acute encephalopathy was difficult by conventional computed tomography (CT), and T1‐ or T2‐weighted magnet resonance (MR) imaging. We report that the diffusion‐weighted (DW) imagin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838264/ https://www.ncbi.nlm.nih.gov/pubmed/29531719 http://dx.doi.org/10.1002/ccr3.1376 |
_version_ | 1783304224108445696 |
---|---|
author | Yoshimi, Mayumi Abe, Shoko |
author_facet | Yoshimi, Mayumi Abe, Shoko |
author_sort | Yoshimi, Mayumi |
collection | PubMed |
description | Methotrexate (MTX)‐induced encephalopathy is a grave complication in patients with malignancies. The early diagnosis of acute encephalopathy was difficult by conventional computed tomography (CT), and T1‐ or T2‐weighted magnet resonance (MR) imaging. We report that the diffusion‐weighted (DW) imaging is useful for early detection of acute leukoencephalopathy. |
format | Online Article Text |
id | pubmed-5838264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58382642018-03-12 Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy Yoshimi, Mayumi Abe, Shoko Clin Case Rep Case Reports Methotrexate (MTX)‐induced encephalopathy is a grave complication in patients with malignancies. The early diagnosis of acute encephalopathy was difficult by conventional computed tomography (CT), and T1‐ or T2‐weighted magnet resonance (MR) imaging. We report that the diffusion‐weighted (DW) imaging is useful for early detection of acute leukoencephalopathy. John Wiley and Sons Inc. 2018-01-22 /pmc/articles/PMC5838264/ /pubmed/29531719 http://dx.doi.org/10.1002/ccr3.1376 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Yoshimi, Mayumi Abe, Shoko Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
title | Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
title_full | Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
title_fullStr | Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
title_full_unstemmed | Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
title_short | Diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
title_sort | diffusion‐weighted imaging characteristics of methotrexate‐induced acute encephalopathy |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838264/ https://www.ncbi.nlm.nih.gov/pubmed/29531719 http://dx.doi.org/10.1002/ccr3.1376 |
work_keys_str_mv | AT yoshimimayumi diffusionweightedimagingcharacteristicsofmethotrexateinducedacuteencephalopathy AT abeshoko diffusionweightedimagingcharacteristicsofmethotrexateinducedacuteencephalopathy |